Mission

HUPO’s mission is to define and promote proteomics through international cooperation and collaborations by fostering the development of new technologies, techniques, and training to better understand human disease.

Its objectives are as follows:

Consortium History

HUPO was launched on Feb. 9, 2001. On that date, a Global Advisory Council (GAC) was officially formed that included leading global experts in the field of proteomics from the academic, government, and commercial sectors. Over the next 12 months, the GAC, in consultation with industry, identified major proteomics issues and initiatives that needed to be addressed by HUPO. Since its inception, HUPO has received substantial financial assistance from Genome Quebec, Montreal International, McGill University, the National Institutes of Health, and pharmaceutical companies, among others. In addition, it has benefited from considerable in-kind contributions of time and energy from GAC members, research institutes, and pharmaceutical company partners around the world.

Since April 2015, the HUPO office has been located in Vancouver, British Columbia, Canada.

HUPO initiatives are prominently showcased at each Annual HUPO World Congress, which are held on a three-year rotation in the Americas, Asia/Oceania, and Europe. Past congresses have been held in cities such as Versailles, France (2002), Montreal, Canada (2003), Beijing, China (2004), Munich, Germany (2005), Long Beach, Calif. (2006), Seoul, Korea (2007), Amsterdam, The Netherlands (2008), and Toronto, Canada (2009). The number of participants and exhibitors has significantly increased over the years, and the Congresses are a must attend for anyone involved in proteomics.

Structure & Governance

The HUPO GAC consists of up to 48 scientists who represent the three global regions of Eastern (Asia-Oceania), Central (Europe-Africa), and Western (the Americas). GAC members serve three-year staggered terms.

HUPO activities are supported and lead by a number of committees, which are composed of HUPO members and GAC members.

The committees are as follows: Awards Committee, Education & Training Committee, Ethics Committee, Finance Committee, Industrial Advisory Board, Membership Committee, Nomination & Elections Committee, and Publications Committee.

Impact/Accomplishment

HUPO is pleased to maintain affiliations with the most important and prestigious proteomics journals. Each of the three affiliated journals, Journal of Proteome Research, Molecular & Cellular Proteomics, and Translational Proteomics has a unique partnership with HUPO.

An important function of HUPO is to foster international initiatives that help to better understand human disease. In 2010 the Human Proteome Project (HPP) was conceptualized and now works in collaboration with almost all of the previously existing HUPO initiatives. These initiatives pre-date HPP, and many conduct projects and activities both with the HPP and independently.

The HUPO Administrative Office is located in Vancouver, British Columbia, Canada.
2101 – 1177 West Hastings Street
Vancouver, BC, Canada, V6E 2K3
phone: 604-558-5498
fax: 1-604-681-1049
email: office@hupo.org

Sponsors & Partners

Membership in HUPO is based on the calendar year (Jan. 1 to Dec. 31.) If a partner joins or renews mid-year, then benefits begin with date of dues payment or approval to the end of the year.

• Agilent Technologies
• Sciex
• Bruker
• Thermo Scientific
• Genentech
• Waters
• Cambridge Isotop Laboratories
• New England Peptide